Drugmaker Merck has agreed to pay $24 million to Massachusetts’ Medicaid program to resolve allegations that it overbilled for certain drugs, according to a Boston Globe report.
The settlement brings an end to Massachusetts’ 2003 lawsuit against 13 drugmakers for price inflation between 1995-2003. Merck appealed a court ruling, delaying its settlement until now. Prior to Merck’s settlement, the state had previously recovered $23.4 million from the other 12 companies.
A Merck spokesperson said the settlement is not a reflection of the company’s wrongdoing but a decision to put the matter behind it.
Related Articles on Pharmaceutical Fraud:
KV Pharmaceutical to Pay $17M to Resolve False Claim Charges
Pfizer Nears Settlement Over Alleged Bribery
GlaxoSmithKline Settles Case Over Drug Pricing, Marketing With $3B
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
